Hypertension and obesity moderate the relationship between β-amyloid and cognitive decline in midlife

Alzheimers Dement. 2019 Mar;15(3):418-428. doi: 10.1016/j.jalz.2018.09.008. Epub 2018 Oct 25.

Abstract

Background: This study tested if central obesity, hypertension, or depressive symptoms moderated the relationship between β-amyloid (Aβ) and longitudinal cognitive performance in late middle-aged adults enriched for Alzheimer's disease (AD) risk.

Methods: Participants (n = 207; ages = 40-70 years; 73% parental AD) in the Wisconsin Registry for Alzheimer's Prevention study completed 3+ neuropsychological evaluations and a [11C]PiB positron emission tomography scan or lumbar puncture. Linear mixed-effects regression models tested interactions of risk factor × Aβ × visit age on longitudinal Verbal Learning & Memory and Speed & Flexibility factor scores.

Results: The relationship between Aβ and Verbal Learning & Memory decline was moderated by hypertension (χ2(1) = 3.85, P = .04) and obesity (χ2(1) = 6.12, P = .01); those with both elevated Aβ and the risk factor declined at faster rates than those with only elevated Aβ or elevated risk factors.

Conclusion: In this cohort, hypertension and obesity moderated the relationship between Aβ and cognitive decline.

Keywords: Depression; Hypertension; Neuropsychology; Obesity; Preclinical Alzheimer's disease; β-amyloid.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Alzheimer Disease / epidemiology
  • Amyloid beta-Peptides / metabolism*
  • Biomarkers / cerebrospinal fluid
  • Brain / diagnostic imaging
  • Brain / metabolism
  • Cognitive Dysfunction / diagnostic imaging
  • Cognitive Dysfunction / epidemiology*
  • Cognitive Dysfunction / metabolism*
  • Depression / diagnostic imaging
  • Depression / epidemiology
  • Depression / metabolism
  • Disease Progression
  • Female
  • Humans
  • Hypertension / diagnostic imaging
  • Hypertension / epidemiology*
  • Hypertension / metabolism
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Obesity, Abdominal / diagnostic imaging
  • Obesity, Abdominal / epidemiology*
  • Obesity, Abdominal / metabolism
  • Positron-Emission Tomography
  • Risk Factors
  • Wisconsin

Substances

  • Amyloid beta-Peptides
  • Biomarkers